APA (7th ed.) Citation

Boulos, J., Saeed, M., Chatterjee, M., Bülbül, Y., Crudo, F., Marko, D., . . . Efferth, T. (2021). Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells. Pharmaceuticals, 14(11), . https://doi.org/10.3390/ph14111126

Chicago Style (17th ed.) Citation

Boulos, Joelle, Mohamed Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine Klauck, and Thomas Efferth. "Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells." Pharmaceuticals 14, no. 11 (2021). https://doi.org/10.3390/ph14111126.

MLA (9th ed.) Citation

Boulos, Joelle, et al. "Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells." Pharmaceuticals, vol. 14, no. 11, 2021, https://doi.org/10.3390/ph14111126.